Get started
Author

Tom Ockhuisen

Trade-offs between clinical performance and test accessibility in tuberculosis diagnosis: a multi-country modelling approach for target product profile development
2024 · Alexandra de Nooy, Tom Ockhuisen, et al. · The Lancet Global Health · 37
Cost-effectiveness of diagnostic tools and strategies for the screening and diagnosis of tuberculosis disease and infection: a scoping review
2024 · Tom Ockhuisen, Alexandra de Nooy, et al. · BMJ Public Health · 14
PDF
Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines)
2024 · Megan A Hansen, Nkgomeleng A Lekodeba, et al. · BMJ Open · 9
PDF
Cost-effectiveness of Targeted Next-Generation Sequencing for Tuberculosis Drug-resistance Testing as an Alternative to the Standard of Care in South Africa
2025 · Alexandra de Nooy, Shaheed Vally Omar, et al. · Clinical Infectious Diseases · 7
PDF
Cost and impact of decentralized tuberculosis testing: a modeling analysis of price thresholds for molecular instruments in high-burden settings
2025 · Tom Ockhuisen, Alexandra de Nooy, et al. · EClinicalMedicine · 3
Guiding the development of the tuberculosis screening target product profile using single-screen and multi-screen approaches: a modelling study
2025 · Alexandra de Nooy, Cecily Miller, et al. · The Lancet Global Health · 3
Impact and cost-effectiveness of SARS-CoV-2 self-testing strategies in schools: a multicountry modelling analysis
2024 · Joshua M Chevalier, Alvin X Han, et al. · BMJ Open · 3
PDF
Cost-effectiveness of SARS-CoV-2 self-testing at routine gatherings to minimize community-level infections in lower-middle income countries: A mathematical modeling study
2024 · Megan A. Hansen, Alvin X. Han, et al. · PLoS ONE · 1
PDF
Works count: 8
Citation count: 77
H-index: 4
I10-index: 2
Year
Topic
Type